Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-144SR (Leuprorelin) GF vs GC in Uterine Fibroids
NCT00776074Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2006
- Primary completion
- Jul 2007
01
Overview
A Phase 2 trial of leuprorelin extended-release injection in Uterine Fibroids (UF), sponsored by Takeda. Started Jun 2006; status: completed.
02
Drugs
leuprorelin extended-release injection
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00776074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776074.